These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31145699)

  • 21. Mechanisms Preserving Insulin Action during High Dietary Fat Intake.
    Lundsgaard AM; Holm JB; Sjøberg KA; Bojsen-Møller KN; Myrmel LS; Fjære E; Jensen BAH; Nicolaisen TS; Hingst JR; Hansen SL; Doll S; Geyer PE; Deshmukh AS; Holst JJ; Madsen L; Kristiansen K; Wojtaszewski JFP; Richter EA; Kiens B
    Cell Metab; 2019 Jan; 29(1):50-63.e4. PubMed ID: 30269983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease.
    Diraison F; Moulin P; Beylot M
    Diabetes Metab; 2003 Nov; 29(5):478-85. PubMed ID: 14631324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis.
    Green CJ; Marjot T; Walsby-Tickle J; Charlton C; Cornfield T; Westcott F; Pinnick KE; Moolla A; Hazlehurst JM; McCullagh J; Tomlinson JW; Hodson L
    Eur J Endocrinol; 2022 Feb; 186(3):367-377. PubMed ID: 35038311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.
    Lambert JE; Ramos-Roman MA; Browning JD; Parks EJ
    Gastroenterology; 2014 Mar; 146(3):726-35. PubMed ID: 24316260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.
    Latorre J; Moreno-Navarrete JM; Mercader JM; Sabater M; Rovira Ò; Gironès J; Ricart W; Fernández-Real JM; Ortega FJ
    Int J Obes (Lond); 2017 Apr; 41(4):620-630. PubMed ID: 28119530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly.
    Flannery C; Dufour S; Rabøl R; Shulman GI; Petersen KF
    Diabetes; 2012 Nov; 61(11):2711-7. PubMed ID: 22829450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation.
    Cui CX; Deng JN; Yan L; Liu YY; Fan JY; Mu HN; Sun HY; Wang YH; Han JY
    J Ethnopharmacol; 2017 Aug; 208():24-35. PubMed ID: 28648927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars.
    Luukkonen PK; Sädevirta S; Zhou Y; Kayser B; Ali A; Ahonen L; Lallukka S; Pelloux V; Gaggini M; Jian C; Hakkarainen A; Lundbom N; Gylling H; Salonen A; Orešič M; Hyötyläinen T; Orho-Melander M; Rissanen A; Gastaldelli A; Clément K; Hodson L; Yki-Järvinen H
    Diabetes Care; 2018 Aug; 41(8):1732-1739. PubMed ID: 29844096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Low Glycemic Index and Glycemic Load Diets on Hepatic Fat Mass, Insulin Resistance, and Blood Lipid Panels in Individuals with Nonalcoholic Fatty Liver Disease.
    Parker A; Kim Y
    Metab Syndr Relat Disord; 2019 Oct; 17(8):389-396. PubMed ID: 31305201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. t10,c12 conjugated linoleic acid upregulates hepatic de novo lipogenesis and triglyceride synthesis via mTOR pathway activation.
    Go GW; Oh S; Park M; Gang G; McLean D; Yang HS; Song MH; Kim Y
    J Microbiol Biotechnol; 2013 Nov; 23(11):1569-76. PubMed ID: 24018969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates.
    Lundsgaard AM; Fritzen AM; Sjøberg KA; Myrmel LS; Madsen L; Wojtaszewski JFP; Richter EA; Kiens B
    Mol Metab; 2017 Jan; 6(1):22-29. PubMed ID: 28123934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Artemisia species on de novo lipogenesis in vivo.
    Rood JC; Schwarz JM; Gettys T; Mynatt RL; Mendoza T; Johnson WD; Cefalu WT
    Nutrition; 2014; 30(7-8 Suppl):S17-20. PubMed ID: 24985100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection.
    Hellerstein MK; Grunfeld C; Wu K; Christiansen M; Kaempfer S; Kletke C; Shackleton CH
    J Clin Endocrinol Metab; 1993 Mar; 76(3):559-65. PubMed ID: 8445011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of prednisolone on parameters of de novo lipogenesis and indices for stearoyl-CoA- and Δ6- desaturase activity in healthy males: A Post-hoc analysis of a randomized, placebo-controlled, double-blind trial.
    Pranger IG; van Raalte DH; Brands M; Muskiet MHA; Kema IP; Serlie MJ; Diamant M; Bakker SJL; Muskiet FAJ
    Prostaglandins Leukot Essent Fatty Acids; 2018 May; 132():8-15. PubMed ID: 29735021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary olive oil and menhaden oil mitigate induction of lipogenesis in hyperinsulinemic corpulent JCR:LA-cp rats: microarray analysis of lipid-related gene expression.
    Deng X; Elam MB; Wilcox HG; Cagen LM; Park EA; Raghow R; Patel D; Kumar P; Sheybani A; Russell JC
    Endocrinology; 2004 Dec; 145(12):5847-61. PubMed ID: 15331573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.